Keywords: roche, foresees, good, outlook, first, months, switzerland
ROCHE FORESEES GOOD OUTLOOK FOR 1993
Article | 03 May 1993
For the first three months of 1993, Switzerland's Hoffmann-La Roche has reported a 7% improvement in sales to 3.5 billion Swiss francs ($2.38 billion. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
